gsrn became our wholly owned subsidiary with the withdrawal of the 51 % majority partner for the full ownership of one center with no other consideration . we made a fair value determination of our original 49 % interest which resulted in a step-up gain of approximately 36 $ 1.3 million . we determined a fair value of the remaining acquired imaging center of $ 3.1 million in assets and $ 426,000 in liabilities were recognized . we recorded $ 1,000 in other assets , $ 679,000 in fixed assets , $ 426,000 in right-of-use assets , $ 426,000 in operating lease liabilities , and $ 2.0 million in goodwill . on august 1 , 2019 we completed a step-up acquisition of our former 25 % owned joint venture , nulogix , via a stock issuance of radnet common shares valued at $ 1.5 million to obtain the remaining 75 % outstanding nulogix shares . we made a fair value determination of the acquired assets and approximately $ 189,000 in fixed assets , $ 732,000 in intangible assets , $ 278,000 in deferred tax liability and goodwill of $ 1.3 million were recorded . we also made a fair value determination of our 25 % pre-existing interest in the business and recognized a loss of $ 504,000 which is included in operating expenses within the consolidated statements of operations . on april 1 , 2019 we completed our acquisition of certain assets of kern radiology imaging systems inc. , consisting of four multi-modality imaging centers located in bakersfield , california for purchase consideration of $ 19.3 million . we made a fair value determination of the acquired assets and assumed liabilities and approximately $ 10.1 million in property and equipment , $ 9.7 million in right-of-use assets , $ 36,000 in other assets , $ 3.4 million in intangible assets , $ 14.5 million in operating lease liabilities , and $ 10.5 million in goodwill were recorded . on april 1 , 2019 we completed our acquisition of certain assets of zilkha radiology inc. consisting of two multi-modality centers located in islip , new york for purchase consideration of $ 4.5 million . we made a fair value determination of the acquired assets and assumed liabilities and approximately $ 2.2 million in property and equipment , $ 5.1 million in right-of-use assets , $ 100,000 in intangible assets , $ 5.1 million in operating lease liabilities , $ 332,000 in finance lease liabilities and $ 2.6 million in goodwill were recorded . on february 28 , 2019 , one of our variable interest entities ( vies ) , lenox hill radiology and medical imaging associates , p.c . ( `` lhr `` ) , purchased the membership interest of hudson valley radiology associates , p.l.l.c . ( `` hvra `` ) for $ 6.0 million of radnet common stock and contingent consideration valued at $ 680,000 to guarantee the share value issued for a period of six months post acquisition date . lhr has performed a fair value purchase price allocation and recorded equipment of $ 10,000 , a covenant not to compete of $ 50,000 , trade name of $ 380,000 , other intangible assets of $ 340,000 and goodwill of $ 3.1 million from the transaction . in connection with the acquisition , radnet also settled against the purchase consideration , $ 2.8 million , net of taxes , of an unfavorable vendor contract with hvra stemming from the previous acquisition of radiologix , inc. in november 2006. on february 1 , 2019 , our majority owned subsidiary , west valley imaging group , llc ( `` wvig `` ) completed its acquisition of certain assets of west valley imaging center , llc ( `` west valley `` ) , consisting of a single multi-modality imaging center located in west hills , ca for purchase consideration of $ 3.0 million all of which was initially funded by the company . we have made a fair value determination of the acquired assets and approximately $ 300,000 in equipment and fixed assets , $ 7,000 in other assets , $ 200,000 in intangible assets and $ 2.5 million in goodwill were recorded . subsequent to the transaction , our partner in wvig , cedars sinai medical center , contributed $ 750,000 in cash to maintain its 25 % economic interest in the venture . on december 3 , 2018 we completed our acquisition of certain assets of orange county diagnostics imaging center consisting of five multi-modality imaging centers located in orange county , california for purchase consideration of $ 6.6 million . we have made a fair valuation determination of the acquired assets and approximately $ 23,000 of current assets , $ 69,000 of other assets , $ 2.8 million of leaseholds and equipment , a $ 50,000 of covenant not to compete , and $ 3.6 million of goodwill were recorded . on november 5 , 2018 we completed our acquisition of certain assets of arcadia radiology imaging consisting of one multi-modality imaging center and one women 's center located in arcadia , california for purchase consideration of $ 3.8 million . we have made a fair value determination of the acquired assets and approximately $ 20,000 of other assets , $ 819,000 of leaseholds , $ 80,000 equipment , $ 300,000 in covenants not to compete , and $ 2.6 million of goodwill were recorded . on november 1 , 2018 we completed our acquisition of certain assets of southern california diagnostic imaging consisting of a multi-modality imaging center located in santa ana , california for purchase consideration of $ 1.4 million . we have made a fair value determination of the acquired assets and approximately $ 18,000 of other assets , $ 1.2 million of leasehold improvements , $ 110,000 of equipment , $ 50,000 of covenants not to compete , and $ 41,000 of goodwill were recorded . story_separator_special_tag see “ liquidity and capital resources ” below for more details on our credit facilities . to mitigate our future interest expense exposure the company has entered into two forward interest rate cap agreements . see derivative instruments section of note 2 to the consolidated financial statements included in this annual report on form 10-k and item 7a , quantitative and qualitative disclosure about market risk below for more details on our derivative transactions . equity in earnings from unconsolidated joint ventures for the twelve months ended december 31 , 2019 we recognized equity in earnings from unconsolidated joint ventures of $ 8.3 million versus $ 11.4 million for the twelve months ended december 31 , 2018 , a decrease of $ 3.0 million or 26.6 % . the decrease was related to the assumption of operational control of the new jersey imaging network which became a consolidated subsidiary on october 1 , 2018. gain on re-measurement valuation of pre-existing interest on august 1 , 2019 we completed a step-up acquisition upon the dissolution of our former 49 % owned joint venture , garden state radiology llc ( `` gsrn `` ) . also on august 1 , 2019 , in a separate transaction , we issued radnet common stock in the amount of $ 1.5 million to acquire a 75 % controlling interest in our formerly 25 % owned joint venture nulogix . in both 43 instances , we made a fair value determination of our original interests , and recorded a step-up gain of approximately $ 1.3 million for the gsrn and recognized a a loss of $ 504,000 on our 25 % pre-existing interest in nulogix . in sum we recorded a net gain on re-measurement of approximately $ 800,000 for the year ended december 31 , 2019 on these transactions . on october 1 , 2018 we completed an step-up acquisition of new jersey imaging network , formerly a joint venture . the change in control was effective upon the execution of an agreement which provided radnet with the ability to make unanimous operating decisions . upon a fair value determination of our 49 % interest in the business of approximately $ 42.5 million , the step-up in valuation from an existing investment caused us to recognize a gain of $ 39.5 million for the year ended december 31 , 2018. other expenses / income for the year ended ended december 31 , 2019 we recorded approximately $ 1.3 million of other expenses and for the year ended december 31 , 2018 we recorded approximately $ 181,000 of other income , respectively . provision for income taxes we had a tax provision for the twelve months ended december 31 , 2019 of $ 6.2 million or 21.0 % of income before income taxes , compared to a tax provision for the twelve months ended december 31 , 2018 of $ 394,000 or 1.0 % of income before income taxes . income tax provision increased in 2019 primarily due to non-recognition of gain on re-measurement of pre-existing interest in the prior year . the income tax rates for the twelve months ended december 31 , 2019 diverge from the federal statutory rate due to noncontrolling interests of the controlled partnerships and the prior year adjustments partially offset by effects of state income taxes . year ended december 31 , 2018 compared to the year ended december 31 , 2017 for the comparison of results of operations for the year ended december 31 , 2018 to the year ended december 31 , 2017 , please see item 7 , management 's discussion and analysis of financial condition and operations in our form 10-k for the year ended december 31 , 2018 , filed with the sec on march 18 , 2019. non-gaap financial measures we use both gaap and non-gaap metrics to measure our financial results . we believe that , in addition to gaap metrics , non-gaap metrics such as adjusted ebitda and free cash flow assist us in measuring our cash generated from operations and ability to service our debt obligations . adjusted ebitda our adjusted ebitda metric removes non-cash and non-recurring charges that occur in the affected period and provides a basis for measuring the company 's core financial performance against other periods . we define adjusted ebitda as earnings before interest , taxes , depreciation and amortization , as adjusted to exclude losses or gains on the disposal of equipment , other income or loss , loss on debt extinguishment , bargain purchase gains , loss on de-consolidation of joint ventures and non-cash equity compensation . adjusted ebitda includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries , and is adjusted for non-cash or one-time events that take place during the period . adjusted ebitda is a non-gaap financial measure used as an analytical indicator by us and the healthcare industry to assess business performance , and is a measure of leverage capacity and ability to service debt . adjusted ebitda should not be considered a measure of financial performance under gaap , and adjusted ebitda should not be considered in isolation or as alternatives to net income , cash flows generated by operating , investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity . adjusted ebitda is not a measurement determined in accordance with gaap and is therefore susceptible to varying methods of calculation , this metric , as presented , may not be comparable to other similarly titled measures of other companies . the following is a reconciliation of the nearest comparable gaap financial measure , net income , to adjusted ebitda for the years ended december 31 , 2019 , 2018 , and 2017 , respectively ( in thousands ) : 44 replace_table_token_19_th free cash flow another non-gaap measure that we use is “ free cash flow ” . we

sources and uses of cash the following table summarizes key components of our sources and uses of cash for the twelve months ended december 31 , 2019 and 2018 : replace_table_token_22_th for cash used in investing activities for the twelve months ended december 31 , 2019 , we purchased property and equipment for approximately $ 74.2 million , acquired imaging facilities for $ 27.2 million , made equity investments at fair value of $ 143,000 and an equity contribution to an existing joint venture of $ 103,000 . we received proceeds from the sale of equipment of $ 1,160,000 . the cash provided by financing activities for the twelve months ended december 31 , 2019 was mainly due to our additional term loan debt issuance of april 18 , 2019 , offset by payments on our term loans and revolving credit facility borrowings . we have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements . these transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers . the aggregate gross amount factored under these facilities for the year ended december 31 , 2019 was approximately $ 9.0 million , inclusive of discount recorded to reflect the difference between market interest rates and the stated interest rate of the receivable . at december 31 , 2019 we have $ 24.2 million , net of discount , remaining to be collected on these agreements . we do not utilize factoring arrangements as an integral part of our financing for working capital . senior credit facilities : at december 31 , 2019 , our barclays credit facilities were comprised of one tranche of term loans ( “ first lien term loans ” ) and a revolving credit facility of $ 137.5 million ( the “ barclays revolving credit facility ” ) , both of which are provided pursuant to the amended and restated first lien credit and guaranty agreement dated july 1 , 2016 ( as amended , the `` first lien credit agreement '' ) .


 Write a concise suspicious activity report of the following text delimited by triple backquotes. Return your response as a formal report which covers the key points highlighting the location,dates,entity names and account holder information in chronological order of the text.
     ```sources and uses of cash the following table summarizes key components of our sources and uses of cash for the twelve months ended december 31 , 2019 and 2018 : replace_table_token_22_th for cash used in investing activities for the twelve months ended december 31 , 2019 , we purchased property and equipment for approximately $ 74.2 million , acquired imaging facilities for $ 27.2 million , made equity investments at fair value of $ 143,000 and an equity contribution to an existing joint venture of $ 103,000 . we received proceeds from the sale of equipment of $ 1,160,000 . the cash provided by financing activities for the twelve months ended december 31 , 2019 was mainly due to our additional term loan debt issuance of april 18 , 2019 , offset by payments on our term loans and revolving credit facility borrowings . we have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements . these transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers . the aggregate gross amount factored under these facilities for the year ended december 31 , 2019 was approximately $ 9.0 million , inclusive of discount recorded to reflect the difference between market interest rates and the stated interest rate of the receivable . at december 31 , 2019 we have $ 24.2 million , net of discount , remaining to be collected on these agreements . we do not utilize factoring arrangements as an integral part of our financing for working capital . senior credit facilities : at december 31 , 2019 , our barclays credit facilities were comprised of one tranche of term loans ( “ first lien term loans ” ) and a revolving credit facility of $ 137.5 million ( the “ barclays revolving credit facility ” ) , both of which are provided pursuant to the amended and restated first lien credit and guaranty agreement dated july 1 , 2016 ( as amended , the `` first lien credit agreement '' ) .
```    
 Suspicious Activity Report : gsrn became our wholly owned subsidiary with the withdrawal of the 51 % majority partner for the full ownership of one center with no other consideration . we made a fair value determination of our original 49 % interest which resulted in a step-up gain of approximately 36 $ 1.3 million . we determined a fair value of the remaining acquired imaging center of $ 3.1 million in assets and $ 426,000 in liabilities were recognized . we recorded $ 1,000 in other assets , $ 679,000 in fixed assets , $ 426,000 in right-of-use assets , $ 426,000 in operating lease liabilities , and $ 2.0 million in goodwill . on august 1 , 2019 we completed a step-up acquisition of our former 25 % owned joint venture , nulogix , via a stock issuance of radnet common shares valued at $ 1.5 million to obtain the remaining 75 % outstanding nulogix shares . we made a fair value determination of the acquired assets and approximately $ 189,000 in fixed assets , $ 732,000 in intangible assets , $ 278,000 in deferred tax liability and goodwill of $ 1.3 million were recorded . we also made a fair value determination of our 25 % pre-existing interest in the business and recognized a loss of $ 504,000 which is included in operating expenses within the consolidated statements of operations . on april 1 , 2019 we completed our acquisition of certain assets of kern radiology imaging systems inc. , consisting of four multi-modality imaging centers located in bakersfield , california for purchase consideration of $ 19.3 million . we made a fair value determination of the acquired assets and assumed liabilities and approximately $ 10.1 million in property and equipment , $ 9.7 million in right-of-use assets , $ 36,000 in other assets , $ 3.4 million in intangible assets , $ 14.5 million in operating lease liabilities , and $ 10.5 million in goodwill were recorded . on april 1 , 2019 we completed our acquisition of certain assets of zilkha radiology inc. consisting of two multi-modality centers located in islip , new york for purchase consideration of $ 4.5 million . we made a fair value determination of the acquired assets and assumed liabilities and approximately $ 2.2 million in property and equipment , $ 5.1 million in right-of-use assets , $ 100,000 in intangible assets , $ 5.1 million in operating lease liabilities , $ 332,000 in finance lease liabilities and $ 2.6 million in goodwill were recorded . on february 28 , 2019 , one of our variable interest entities ( vies ) , lenox hill radiology and medical imaging associates , p.c . ( `` lhr `` ) , purchased the membership interest of hudson valley radiology associates , p.l.l.c . ( `` hvra `` ) for $ 6.0 million of radnet common stock and contingent consideration valued at $ 680,000 to guarantee the share value issued for a period of six months post acquisition date . lhr has performed a fair value purchase price allocation and recorded equipment of $ 10,000 , a covenant not to compete of $ 50,000 , trade name of $ 380,000 , other intangible assets of $ 340,000 and goodwill of $ 3.1 million from the transaction . in connection with the acquisition , radnet also settled against the purchase consideration , $ 2.8 million , net of taxes , of an unfavorable vendor contract with hvra stemming from the previous acquisition of radiologix , inc. in november 2006. on february 1 , 2019 , our majority owned subsidiary , west valley imaging group , llc ( `` wvig `` ) completed its acquisition of certain assets of west valley imaging center , llc ( `` west valley `` ) , consisting of a single multi-modality imaging center located in west hills , ca for purchase consideration of $ 3.0 million all of which was initially funded by the company . we have made a fair value determination of the acquired assets and approximately $ 300,000 in equipment and fixed assets , $ 7,000 in other assets , $ 200,000 in intangible assets and $ 2.5 million in goodwill were recorded . subsequent to the transaction , our partner in wvig , cedars sinai medical center , contributed $ 750,000 in cash to maintain its 25 % economic interest in the venture . on december 3 , 2018 we completed our acquisition of certain assets of orange county diagnostics imaging center consisting of five multi-modality imaging centers located in orange county , california for purchase consideration of $ 6.6 million . we have made a fair valuation determination of the acquired assets and approximately $ 23,000 of current assets , $ 69,000 of other assets , $ 2.8 million of leaseholds and equipment , a $ 50,000 of covenant not to compete , and $ 3.6 million of goodwill were recorded . on november 5 , 2018 we completed our acquisition of certain assets of arcadia radiology imaging consisting of one multi-modality imaging center and one women 's center located in arcadia , california for purchase consideration of $ 3.8 million . we have made a fair value determination of the acquired assets and approximately $ 20,000 of other assets , $ 819,000 of leaseholds , $ 80,000 equipment , $ 300,000 in covenants not to compete , and $ 2.6 million of goodwill were recorded . on november 1 , 2018 we completed our acquisition of certain assets of southern california diagnostic imaging consisting of a multi-modality imaging center located in santa ana , california for purchase consideration of $ 1.4 million . we have made a fair value determination of the acquired assets and approximately $ 18,000 of other assets , $ 1.2 million of leasehold improvements , $ 110,000 of equipment , $ 50,000 of covenants not to compete , and $ 41,000 of goodwill were recorded . story_separator_special_tag see “ liquidity and capital resources ” below for more details on our credit facilities . to mitigate our future interest expense exposure the company has entered into two forward interest rate cap agreements . see derivative instruments section of note 2 to the consolidated financial statements included in this annual report on form 10-k and item 7a , quantitative and qualitative disclosure about market risk below for more details on our derivative transactions . equity in earnings from unconsolidated joint ventures for the twelve months ended december 31 , 2019 we recognized equity in earnings from unconsolidated joint ventures of $ 8.3 million versus $ 11.4 million for the twelve months ended december 31 , 2018 , a decrease of $ 3.0 million or 26.6 % . the decrease was related to the assumption of operational control of the new jersey imaging network which became a consolidated subsidiary on october 1 , 2018. gain on re-measurement valuation of pre-existing interest on august 1 , 2019 we completed a step-up acquisition upon the dissolution of our former 49 % owned joint venture , garden state radiology llc ( `` gsrn `` ) . also on august 1 , 2019 , in a separate transaction , we issued radnet common stock in the amount of $ 1.5 million to acquire a 75 % controlling interest in our formerly 25 % owned joint venture nulogix . in both 43 instances , we made a fair value determination of our original interests , and recorded a step-up gain of approximately $ 1.3 million for the gsrn and recognized a a loss of $ 504,000 on our 25 % pre-existing interest in nulogix . in sum we recorded a net gain on re-measurement of approximately $ 800,000 for the year ended december 31 , 2019 on these transactions . on october 1 , 2018 we completed an step-up acquisition of new jersey imaging network , formerly a joint venture . the change in control was effective upon the execution of an agreement which provided radnet with the ability to make unanimous operating decisions . upon a fair value determination of our 49 % interest in the business of approximately $ 42.5 million , the step-up in valuation from an existing investment caused us to recognize a gain of $ 39.5 million for the year ended december 31 , 2018. other expenses / income for the year ended ended december 31 , 2019 we recorded approximately $ 1.3 million of other expenses and for the year ended december 31 , 2018 we recorded approximately $ 181,000 of other income , respectively . provision for income taxes we had a tax provision for the twelve months ended december 31 , 2019 of $ 6.2 million or 21.0 % of income before income taxes , compared to a tax provision for the twelve months ended december 31 , 2018 of $ 394,000 or 1.0 % of income before income taxes . income tax provision increased in 2019 primarily due to non-recognition of gain on re-measurement of pre-existing interest in the prior year . the income tax rates for the twelve months ended december 31 , 2019 diverge from the federal statutory rate due to noncontrolling interests of the controlled partnerships and the prior year adjustments partially offset by effects of state income taxes . year ended december 31 , 2018 compared to the year ended december 31 , 2017 for the comparison of results of operations for the year ended december 31 , 2018 to the year ended december 31 , 2017 , please see item 7 , management 's discussion and analysis of financial condition and operations in our form 10-k for the year ended december 31 , 2018 , filed with the sec on march 18 , 2019. non-gaap financial measures we use both gaap and non-gaap metrics to measure our financial results . we believe that , in addition to gaap metrics , non-gaap metrics such as adjusted ebitda and free cash flow assist us in measuring our cash generated from operations and ability to service our debt obligations . adjusted ebitda our adjusted ebitda metric removes non-cash and non-recurring charges that occur in the affected period and provides a basis for measuring the company 's core financial performance against other periods . we define adjusted ebitda as earnings before interest , taxes , depreciation and amortization , as adjusted to exclude losses or gains on the disposal of equipment , other income or loss , loss on debt extinguishment , bargain purchase gains , loss on de-consolidation of joint ventures and non-cash equity compensation . adjusted ebitda includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries , and is adjusted for non-cash or one-time events that take place during the period . adjusted ebitda is a non-gaap financial measure used as an analytical indicator by us and the healthcare industry to assess business performance , and is a measure of leverage capacity and ability to service debt . adjusted ebitda should not be considered a measure of financial performance under gaap , and adjusted ebitda should not be considered in isolation or as alternatives to net income , cash flows generated by operating , investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity . adjusted ebitda is not a measurement determined in accordance with gaap and is therefore susceptible to varying methods of calculation , this metric , as presented , may not be comparable to other similarly titled measures of other companies . the following is a reconciliation of the nearest comparable gaap financial measure , net income , to adjusted ebitda for the years ended december 31 , 2019 , 2018 , and 2017 , respectively ( in thousands ) : 44 replace_table_token_19_th free cash flow another non-gaap measure that we use is “ free cash flow ” . we

